Home › Epstein-Barr Virus Infections › California
Epstein-Barr Virus Infections clinical trials in California
4 studies for Epstein-Barr Virus Infections are looking for participants at sites in California.
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
- Loma Linda University Medical Center (Adults only), Loma Linda
- Children's Hospital Los Angeles, Div. of Research Immunology/BMT (Adults and Pediatrics), Los Angeles
RecruitingPhase 3
All ages · All sexes · Updated Sep 2, 2026 · NCT03394365Induction Chemotherapy Response-Guided Radiation for EBV-Associated Nasopharyngeal Carcinoma
- University of California, San Francisco, San Francisco
Recruiting
Ages 18 and older · All sexes · Updated Jun 17, 2026 · NCT06682442Viral Specific T-Lymphocytes to Treat Infection With Adenovirus, Cytomegalovirus or Epstein-Barr Virus in Patients With Compromised Immunity
- Lucile Packard Children's Hospital, Palo Alto
- Lucile Packard Children's Hospital, Palo Alto
RecruitingPhase 1/2
1 Month – 65 Years · All sexes · Updated Aug 14, 2025 · NCT06909110EBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV Infection
- Children's Hosptial Los Angeles, Los Angeles
- University of California San Francisco, San Francisco
RecruitingPhase 2
1 Month – 79 Years · All sexes · Updated Aug 8, 2025 · NCT03266653From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.